NSND OSCC frequently exhibits a distinct immunological profile with higher tumor-infiltrating lymphocytes and PD-L1 expression, potentially favoring immunotherapy, though prognosis remains heterogeneous-better in some cohorts due to fewer comorbidities, yet worse in young patients with higher recurrence and second primary tumor risks. Here, CD274 is linked to neoplasm.